wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q50421953-2F498C2B-6C51-4A13-94E2-7BFBC8E51619
Q50421953-2F498C2B-6C51-4A13-94E2-7BFBC8E51619
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50421953-2F498C2B-6C51-4A13-94E2-7BFBC8E51619
Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV.
P2860
Q50421953-2F498C2B-6C51-4A13-94E2-7BFBC8E51619
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50421953-2F498C2B-6C51-4A13-94E2-7BFBC8E51619
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d06adb0dcc56f7960748227038e6ed5e6e5dd8a8
P2860
Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib: results from the randomized CML-study IV.